Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Obesity 13Breast Neoplasms 4Neoplasms 3Sexual Dysfunction, Physiological 2Pulmonary Disease, Chronic Obstructive 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Overweight 2Endometrial Neoplasms 2Dyspnea 2Constipation 2Colorectal Neoplasms 2Weight Loss 1Vomiting 1Uterine Cervical Neoplasms 1Syndrome 1Sexual Dysfunctions, Psychological 1Pediatric Obesity 1Pain 1Osteoporosis 1Nausea 1Mucositis 1Motor Activity 1Metabolic Diseases 1Lung Neoplasms 1Lung Diseases, Interstitial 1Li-Fraumeni Syndrome 1Leukemia 1Intermittent Fasting 1Inflammatory Breast Neoplasms 1

Interventions

Tirzepatide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperplasia × Other × 30 days × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡